Pra Health Sciences Inc (PRAH) Gross Profit Margin starting from the first quarter 2021 to first quarter 2020, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Pra Health Sciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRAH Gross Profit Margin (Mar 31 2021)
Q1 		(Dec 31 2020)
Q4 		(Sep 30 2020)
Q3 		(Jun 30 2020)
Q2 		(Mar 31 2020)
Q1
Y / Y Revenue Change 19.15 %
Seq. Revenue Change 6.91 %
Revenue In Millions $933.78
Gross Profit Margin 49.45 %
Gross Profit Margin Total Ranking # 2002
Gross Profit In Millions $461.77
Y / Y Gross Profit Change 21.57 %
Seq. Gross Profit Change 5.97 %


Commenting First Quarter 2021 Gross Profit Margin
Pra Health Sciences Inc has managed to improve its Revenue sequentially to $933.78 millions by 6.91 % faster than Gross Profit increase of 5.97 % to $461.77 millions, this led to contraction in Gross Profit Margin to 49.45 %, but the Pra Health Sciences Inc I. Quarter Gross Profit Margin remained above company average rate of 45.69%.


Observing first quarter 2021 results within Medical Laboratories industry 17 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1756 to 2002.
Learn about Gross Margin
PRAH's Gross Profit Margin first quarter 2021 Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 361
Overall # 1953

Gross Profit Margin Statistics
High Average Low
49.89 % 45.69 % 41.05 %
(Dec 31 2020)   (Mar 31 2017)


PRAH Gross Income Trends • More of PRAH's Profitabilty Ratios • PRAH Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PRAH's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PRAH's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PRAH's Competitors
Gross Profit Margin Profit Margin for Pra Health Sciences Inc 's Suppliers
Gross Profit Margin Profit Margin for PRAH's Customers

You may also want to know
PRAH's Annual Growth Rates PRAH's Profitability Ratios PRAH's Asset Turnover Ratio PRAH's Dividend Growth
PRAH's Roe PRAH's Valuation Ratios PRAH's Financial Strength Ratios PRAH's Gross Profit Growth
PRAH's Roa PRAH's Inventory Turnover Ratio PRAH's Growth Rates PRAH's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2021, within Medical Laboratories Industry Gross Profit MarginMar 31 2021 MRQ Gross ProfitMar 31 2021 MRQ Revenue
Incyte Corporation  95.17 %$ 575.498  Millions$ 604.718  Millions
Maxcyte inc   89.33 %$ 5.802  Millions$ 6.495  Millions
Castle Biosciences Inc   86.73 %$ 19.785  Millions$ 22.813  Millions
U s Stem Cell Inc   81.61 %$ 0.069  Millions$ 0.084  Millions
Fulgent Genetics Inc   79.39 %$ 285.354  Millions$ 359.429  Millions
Caredx Inc   75.54 %$ 50.917  Millions$ 67.400  Millions
Exact Sciences Corporation  72.64 %$ 292.084  Millions$ 402.077  Millions
Hologic Inc  70.62 %$ 1,085.800  Millions$ 1,537.600  Millions
Veracyte Inc   70.49 %$ 25.871  Millions$ 36.703  Millions
Nrc Health  66.33 %$ 23.524  Millions$ 35.464  Millions
Ppd Inc   60.04 %$ 827.613  Millions$ 1,378.380  Millions
Vyant Bio Inc   59.91 %$ 0.133  Millions$ 0.222  Millions
Natera Inc   59.74 %$ 90.994  Millions$ 152.316  Millions
Exagen Inc   55.50 %$ 5.876  Millions$ 10.587  Millions
Renalytix Plc  52.90 %$ 0.255  Millions$ 0.482  Millions
Butterfly Network Inc   51.56 %$ 6.416  Millions$ 12.443  Millions
Luna Innovations Inc  51.06 %$ 13.429  Millions$ 26.299  Millions
Pra Health Sciences Inc   49.45 %$ 461.765  Millions$ 933.775  Millions
Charles River Laboratories International inc   48.58 %$ 400.591  Millions$ 824.566  Millions
American Shared Hospital Services  45.29 %$ 1.434  Millions$ 3.166  Millions
Psychemedics Corporation  44.95 %$ 2.568  Millions$ 5.713  Millions
Quest Diagnostics Inc  40.22 %$ 1,094.000  Millions$ 2,720.000  Millions
Labcorp Holdings Inc   38.42 %$ 1,599.000  Millions$ 4,161.500  Millions
Personalis Inc   35.57 %$ 7.427  Millions$ 20.881  Millions
Inotiv Inc   33.49 %$ 6.280  Millions$ 18.751  Millions
Capforce Inc   33.22 %$ 0.276  Millions$ 0.830  Millions
Iqvia Holdings Inc   32.74 %$ 1,116.000  Millions$ 3,409.000  Millions
Medpace Holdings Inc   30.17 %$ 78.427  Millions$ 259.965  Millions
Invitae Corporation  27.15 %$ 28.130  Millions$ 103.621  Millions
Syneos Health Inc   21.80 %$ 263.495  Millions$ 1,208.745  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.